loadpatents
Patent applications and USPTO patent grants for REGULA; Joerg Thomas.The latest application filed is for "bispecific anti-human cd20/human transferrin receptor antibodies and methods of use".
Patent | Date |
---|---|
Bispecific Anti-human Cd20/human Transferrin Receptor Antibodies And Methods Of Use App 20220306761 - DUERR; Harald ;   et al. | 2022-09-29 |
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer App 20220259327 - Amann; Maria ;   et al. | 2022-08-18 |
Bispecific Antibodies Specific For Pd1 And Tim3 App 20220259314 - CODARRI-DEAK; LAURA ;   et al. | 2022-08-18 |
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer App 20220259326 - Amann; Maria ;   et al. | 2022-08-18 |
Bispecific Anti-human A-beta/human Transferrin Receptor Antibodies And Methods Of Use App 20220144963 - Duerr; Harald ;   et al. | 2022-05-12 |
Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer Grant 11,306,154 - Amann , et al. April 19, 2 | 2022-04-19 |
Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer Grant 11,267,903 - Amann , et al. March 8, 2 | 2022-03-08 |
Tetravalent Multispecific Antibodies App 20220049020 - REGULA; Joerg Thomas ;   et al. | 2022-02-17 |
Antibodies Against Human Angiopoietin 2 App 20210388071 - Brinkmann; Ulrich ;   et al. | 2021-12-16 |
Multispecific Antibodies App 20210309730 - SCHAEFER; Wolfgang ;   et al. | 2021-10-07 |
Bispecific Anti-human A-beta/human Transferrin Receptor Antibodies And Methods Of Use App 20210301030 - Duerr; Harald ;   et al. | 2021-09-30 |
Bispecific antibodies specific for PD1 and TIM3 Grant 11,130,810 - Codarri-Deak , et al. September 28, 2 | 2021-09-28 |
Bispecific T cell activating antigen binding molecules Grant 11,117,965 - Ast , et al. September 14, 2 | 2021-09-14 |
Human FcRn-binding modified antibodies and methods of use Grant 11,091,541 - Hartmann , et al. August 17, 2 | 2021-08-17 |
Method For Determining The In Vivo Interaction Mode App 20210198383 - MOELLEKEN; Joerg ;   et al. | 2021-07-01 |
Spr-based Bridging Assay Format For Determining The Biological Activity Of Multivalent, Multispecific Molecules App 20210199666 - Papadimitriou; Apollon ;   et al. | 2021-07-01 |
Bispecific Anti-vegf/anti-ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases App 20210095013 - Duerr; Harald ;   et al. | 2021-04-01 |
Bispecific T Cell Activating Antigen Binding Molecules App 20210070882 - BACAC; Marina ;   et al. | 2021-03-11 |
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use Grant 10,941,205 - Duerr , et al. March 9, 2 | 2021-03-09 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20210047394 - Baehner; Monika ;   et al. | 2021-02-18 |
Bispecific Antigen Binding Proteins App 20200369758 - IMHOF-JUNG; Sabine ;   et al. | 2020-11-26 |
Bispecific T Cell Activating Antigen Binding Molecules App 20200347147 - BACAC; Marina ;   et al. | 2020-11-05 |
Nucleic acid encoding dual Fc antigen binding proteins Grant 10,793,621 - Bossenmaier , et al. October 6, 2 | 2020-10-06 |
Bispecific T cell activating antigen binding molecules Grant 10,766,967 - Bacac , et al. Sep | 2020-09-08 |
Antibodies Against Human Angiopoietin 2 App 20200262904 - Brinkmann; Ulrich ;   et al. | 2020-08-20 |
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer App 20200247904 - Kind Code | 2020-08-06 |
Bispecific antibodies and methods of use in ophthalmology Grant 10,730,938 - Bedoucha , et al. | 2020-08-04 |
Bispecific T Cell Activating Antigen Binding Molecules App 20200231673 - AST; Oliver ;   et al. | 2020-07-23 |
Bispecific Anti-human Cd20/human Transferrin Receptor Antibodies And Methods Of Use App 20200216554 - DUERR; Harald ;   et al. | 2020-07-09 |
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases Grant 10,683,345 - Duerr , et al. | 2020-06-16 |
Fc-receptor Binding Modified Asymmetric Antibodies And Methods Of Use App 20200172607 - Regula; Joerg Thomas ;   et al. | 2020-06-04 |
Bispecific antigen binding proteins Grant 10,640,555 - Imhof-Jung , et al. | 2020-05-05 |
Bispecific T cell activating antigen binding molecules Grant 10,611,841 - Ast , et al. | 2020-04-07 |
Bispecific T cell activating antigen binding molecules Grant 10,611,840 - Ast , et al. | 2020-04-07 |
Monovalent antigen binding proteins Grant 10,611,825 - Bossenmaier , et al. | 2020-04-07 |
Fc-receptor Binding Modified Asymmetric Antibodies And Methods Of Use App 20200095310 - Regula; Joerg Thomas ;   et al. | 2020-03-26 |
Anti-ANG2 antibodies and methods of use Grant 10,538,585 - Dengl , et al. Ja | 2020-01-21 |
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer App 20190382507 - Amann; Maria ;   et al. | 2019-12-19 |
Bispecific Antibodies Specific For Pd1 And Tim3 App 20190322748 - CODARRI-DEAK; LAURA ;   et al. | 2019-10-24 |
Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Grant 10,392,445 - Amann , et al. A | 2019-08-27 |
Bispecific antibodies specific for PD1 and TIM3 Grant 10,287,352 - Codarri-Deak , et al. | 2019-05-14 |
Method For Determining The In Vivo Interaction Mode App 20190016827 - MOELLEKEN; Joerg ;   et al. | 2019-01-17 |
Antigen Binding Proteins App 20180312573 - BOSSENMAIER; Birgit ;   et al. | 2018-11-01 |
Bispecific antibodies Grant 10,106,600 - Brinkmann , et al. October 23, 2 | 2018-10-23 |
Antibodies Against Human Angiopoietin 2 App 20180282404 - Brinkmann; Ulrich ;   et al. | 2018-10-04 |
Anti-cd3xrob04 Bispecific T Cell Activating Antigen Binding Molecules App 20180282410 - AST; Oliver ;   et al. | 2018-10-04 |
Anti-PDGF-B antibodies and methods of use Grant 10,087,246 - Bedoucha , et al. October 2, 2 | 2018-10-02 |
Bispecific T Cell Activating Antigen Binding Molecules App 20180222980 - AST; Oliver ;   et al. | 2018-08-09 |
Bispecific Anti-human A-beta/human Transferrin Receptor Antibodies And Methods Of Use App 20180222992 - Duerr; Harald ;   et al. | 2018-08-09 |
Bispecific Anti-human Cd20/human Transferrin Receptor Antibodies And Methods Of Use App 20180222993 - DUERR; Harald ;   et al. | 2018-08-09 |
Bispecific T Cell Activating Antigen Binding Molecules App 20180222981 - AST; Oliver ;   et al. | 2018-08-09 |
Immunoglobulin Glycosylation Pattern Analysis App 20180164325 - Koll; Hans ;   et al. | 2018-06-14 |
Dual FC antigen binding proteins Grant 9,982,036 - Bossenmaier , et al. May 29, 2 | 2018-05-29 |
Bispecific Antigen Binding Proteins App 20180079805 - IMHOF-JUNG; Sabine ;   et al. | 2018-03-22 |
Bispecific T cell activating antigen binding molecules Grant 9,914,776 - Ast , et al. March 13, 2 | 2018-03-13 |
Monovalent Antigen Binding Proteins App 20180037633 - BOSSENMAIER; Birgit ;   et al. | 2018-02-08 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20170369566 - Baehner; Monika ;   et al. | 2017-12-28 |
Multispecific Antibodies App 20170349669 - IMHOF-JUNG; SABINE ;   et al. | 2017-12-07 |
Bispecific Anti-vegf/anti-ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases App 20170260265 - Duerr; Harald ;   et al. | 2017-09-14 |
Anti-pdgf-b Antibodies And Methods Of Use App 20170247440 - Bedoucha; Marc ;   et al. | 2017-08-31 |
Anti-ang2 Antibodies And Methods Of Use App 20170247441 - Dengl; Stefan ;   et al. | 2017-08-31 |
Bispecific Antibodies And Methods Of Use In Ophthalmology App 20170240629 - Bedoucha; Marc ;   et al. | 2017-08-24 |
Bispecific, Bivalent Anti-vegf/anti-ang-2 Antibodies App 20170240626 - Baehner; Monika ;   et al. | 2017-08-24 |
Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) Grant 9,724,425 - Amrein , et al. August 8, 2 | 2017-08-08 |
Bispecific anti-VEGF/anti-ANG-2 antibodies Grant 9,708,396 - Baehner , et al. July 18, 2 | 2017-07-18 |
Bispecific T Cell Activating Antigen Binding Molecules App 20170190783 - Bacac; Marina ;   et al. | 2017-07-06 |
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases Grant 9,695,233 - Duerr , et al. July 4, 2 | 2017-07-04 |
Bispecific T Cell Activating Antigen Binding Molecules App 20170174786 - Bacac; Marina ;   et al. | 2017-06-22 |
Bispecific antigen binding proteins Grant 9,676,845 - Imhof-Jung , et al. June 13, 2 | 2017-06-13 |
Tetravalent Multispecific Antibodies App 20170145116 - REGULA; JOERG THOMAS ;   et al. | 2017-05-25 |
Multispecific Antibodies App 20170129962 - REGULA; JOERG THOMAS ;   et al. | 2017-05-11 |
Bispecific Antibodies Specific For Pd1 And Tim3 App 20170114135 - CODARRI-DEAK; LAURA ;   et al. | 2017-04-27 |
Bispecific T cell activating antigen binding molecules App 20170114146 - Klein; Christian ;   et al. | 2017-04-27 |
Bispecific T Cell Activating Antigen Binding Molecules App 20170096495 - BACAC; Marina ;   et al. | 2017-04-06 |
Bispecific T Cell Activating Antigen Binding Molecules App 20170096485 - BACAC; Marina ;   et al. | 2017-04-06 |
Antibodies Against Human Angiopoietin 2 App 20170029493 - Brinkmann; Ulrich ;   et al. | 2017-02-02 |
Spr-based Bridging Assay Format For Determining The Biological Activity Of Multivalent, Multispecific Molecules App 20170003295 - Papadimitriou; Apollon ;   et al. | 2017-01-05 |
Antigen Binding Molecules Comprising A Tnf Family Ligand Trimer App 20160200833 - Amann; Maria ;   et al. | 2016-07-14 |
Fc-receptor Binding Modified Asymmetric Antibodies And Methods Of Use App 20160194389 - Regula; Joerg Thomas ;   et al. | 2016-07-07 |
Multispecific antibodies comprising full length antibodies and single chain fab fragments Grant 9,382,323 - Brinkmann , et al. July 5, 2 | 2016-07-05 |
Human Fcrn-binding Modified Antibodies And Methods Of Use App 20160159894 - Hartmann; Guido ;   et al. | 2016-06-09 |
Fcrn-binding Abolished Anti-igf-1r Antibodies And Their Use In The Treatment Of Vascular Eye Diseases App 20160151487 - Hartmann; Guido ;   et al. | 2016-06-02 |
Antibodies against human angiopoietin 2 Grant 9,340,609 - Brinkmann , et al. May 17, 2 | 2016-05-17 |
Bispecific T Cell Activating Antigen Binding Molecules App 20160075785 - Ast; Oliver ;   et al. | 2016-03-17 |
Fc-receptor Binding Modified Asymmetric Antibodies And Methods Of Use App 20160068613 - REGULA; Joerg Thomas ;   et al. | 2016-03-10 |
Multispecific Antibodies App 20150315296 - SCHAEFER; WOLFGANG ;   et al. | 2015-11-05 |
Antibodies Against Human Angiopoietin 2 App 20150284457 - Brinkmann; Ulrich ;   et al. | 2015-10-08 |
Antibodies against human angiopoietin 2 Grant 9,109,027 - Brinkmann , et al. August 18, 2 | 2015-08-18 |
Bispecific, Bivalent Anti-vegf/anti-ang2 Antibodies App 20150191535 - Baehner; Monika ;   et al. | 2015-07-09 |
Antibodies against human angiopoietin 2 Grant 9,073,986 - Brinkmann , et al. July 7, 2 | 2015-07-07 |
Conjugates Of Insulin-like Growth Factor-1 And Poly(ethylene Glycol) App 20150099699 - Amrein; Beat ;   et al. | 2015-04-09 |
Bispecific, Tetravalent Antigen Binding Proteins App 20150044214 - IMHOF-JUNG; Sabine ;   et al. | 2015-02-12 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20150004166 - Baehner; Monika ;   et al. | 2015-01-01 |
Bispecific, tetravalent antigen binding proteins Grant 8,703,132 - Imhof-Jung , et al. April 22, 2 | 2014-04-22 |
Bispecific anti-VEGF/anti-ANG-2 antibodies Grant 8,703,130 - Baehner , et al. April 22, 2 | 2014-04-22 |
Antibodies Against Human Angiopoietin 2 App 20140065151 - Brinkmann; Ulrich ;   et al. | 2014-03-06 |
Antibodies Against Human Angiopoietin 2 App 20140065707 - BRINKMANN; ULRICH ;   et al. | 2014-03-06 |
Bispecific Anti-VEGF/Anti-ANG-2 Antibodies and their use in the Treatment of Ocular Vascular Diseases App 20140017244 - Duerr; Harald ;   et al. | 2014-01-16 |
Method for the production of insulin-like growth factor-1 Grant 8,552,158 - Fischer , et al. October 8, 2 | 2013-10-08 |
Conjugates Of Insulin-like Growth Factor-1 And Poly(ethylene Glycol) App 20130217623 - AMREIN; BEAT ;   et al. | 2013-08-22 |
Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) Grant 8,476,232 - Fischer , et al. July 2, 2 | 2013-07-02 |
Antibodies Against Human Angiopoietin 2 App 20130156789 - Brinkmann; Ulrich ;   et al. | 2013-06-20 |
Antibodies against human angiopoietin 2 Grant 8,399,626 - Brinkmann , et al. March 19, 2 | 2013-03-19 |
Method For The Production Of Conjugates Of Insulin-like Growth Factor-1 And Poly(ethylene Glycol) App 20130065831 - Fischer; Stephan ;   et al. | 2013-03-14 |
Antibodies against human angiopoietin 2 Grant 8,361,747 - Brinkmann , et al. January 29, 2 | 2013-01-29 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20120321627 - Baehner; Monika ;   et al. | 2012-12-20 |
Antigen Binding Proteins App 20120237506 - Bossenmaier; Birgit ;   et al. | 2012-09-20 |
Monovalent Antigen Binding Proteins App 20120237507 - Bossenmaier; Birgit ;   et al. | 2012-09-20 |
Bispecific anti-VEGF/anti-ANG-2 antibodies Grant 8,268,314 - Baehner , et al. September 18, 2 | 2012-09-18 |
Antibodies Against Human Angiopoietin 2 App 20120141500 - BRINKMANN; ULRICH ;   et al. | 2012-06-07 |
Antibodies Against Human Angiopoietin 2 App 20120142091 - BRINKMANN; ULRICH ;   et al. | 2012-06-07 |
Antibodies against human angiopoietin 2 Grant 8,133,979 - Brinkmann , et al. March 13, 2 | 2012-03-13 |
Bispecific Antibodies App 20110293613 - BRINKMANN; ULRICH ;   et al. | 2011-12-01 |
Immunoglobulin Glycosylation Pattern Analysis App 20110294150 - Koll; Hans ;   et al. | 2011-12-01 |
Bispecific, Bivalent Anti-vegf/anti-ang-2 Antibodies App 20110236388 - Baehner; Monika ;   et al. | 2011-09-29 |
HUMAN Fc GAMMA RECEPTOR III App 20110183354 - BRINKMANN; ULRICH ;   et al. | 2011-07-28 |
Antibodies Against Il-13 Receptor Alpha 1 And Uses Thereof App 20110086026 - Endl; Josef ;   et al. | 2011-04-14 |
Bispecific, Tetravalent Antigen Binding Proteins App 20100322934 - Imhof-Jung; Sabine ;   et al. | 2010-12-23 |
Bispecific Antigen Binding Proteins App 20100316645 - Imhof-Jung; Sabine ;   et al. | 2010-12-16 |
Stability Testing Of Antibodies App 20100261216 - Eser; Bianca ;   et al. | 2010-10-14 |
Multispecific Antibodies Comprising Full Length Antibodies And Single Chain Fab Fragments App 20100256338 - Brinkmann; Ulrich ;   et al. | 2010-10-07 |
Antibodies against IL-13 receptor alpha1 and uses thereof Grant 7,807,158 - Endl , et al. October 5, 2 | 2010-10-05 |
Method For The Production Of Conjugates Of Insulin-like Growth Factor-1 And Poly(ethylene Glycol) App 20100210547 - Fischer; Stephan ;   et al. | 2010-08-19 |
Antibodies Against Human Angiopoietin 2 App 20100159587 - Brinkmann; Ulrich ;   et al. | 2010-06-24 |
Method For The Production Of Insulin-like Growth Factor-1 App 20100121036 - Fischer; Stephan ;   et al. | 2010-05-13 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20100111967 - Baehner; Monika ;   et al. | 2010-05-06 |
Method For The Production Of Conjugates Of Insulin-like Growth Factor-1 And Poly(ethylene Glycol) App 20100035817 - Fischer; Stephan ;   et al. | 2010-02-11 |
Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) Grant 7,625,996 - Fischer , et al. December 1, 2 | 2009-12-01 |
HUMAN Fc GAMMA RECEPTOR III App 20080248510 - Brinkmann; Ulrich ;   et al. | 2008-10-09 |
Method For The Production Of Conjugates Of Insulin-like Growth Factor-1 And Poly(ethylene Glycol) App 20080119409 - Fischer; Stephan ;   et al. | 2008-05-22 |
Antibodies against IL-13 receptor alpha1 and uses thereof App 20060263356 - Endl; Josef ;   et al. | 2006-11-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.